Immunohistochemical (IHC) staining using antibodies specific for the proliferation marker (Ki-67) and apoptosis markers (BCL-2) further validated the inhibitory effect of circ_0001766 on tumor progression (Fig. 3C). Here, BCL2 is linked to neoplasm.